198 related articles for article (PubMed ID: 25937867)
1. Aetiological factors of Budd-Chiari syndrome in Algeria.
Afredj N; Guessab N; Nani A; Faraoun SA; Ouled Cheikh I; Kerbouche R; Hannoun D; Amir ZC; Ait Kaci H; Bentabak K; Plessier A; Valla DC; Cazals-Hatem V; Denninger MH; Boucekkine T; Debzi N
World J Hepatol; 2015 Apr; 7(6):903-9. PubMed ID: 25937867
[TBL] [Abstract][Full Text] [Related]
2. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome.
Khan F; Armstrong MJ; Mehrzad H; Chen F; Neil D; Brown R; Cain O; Tripathi D
Aliment Pharmacol Ther; 2019 Apr; 49(7):840-863. PubMed ID: 30828850
[TBL] [Abstract][Full Text] [Related]
3. Redefining Budd-Chiari syndrome: A systematic review.
Shin N; Kim YH; Xu H; Shi HB; Zhang QQ; Colon Pons JP; Kim D; Xu Y; Wu FY; Han S; Lee BB; Li LS
World J Hepatol; 2016 Jun; 8(16):691-702. PubMed ID: 27326316
[TBL] [Abstract][Full Text] [Related]
4. A Nationwide Analysis of Budd-Chiari Syndrome in the United States.
Alukal JJ; Zhang T; Thuluvath PJ
J Clin Exp Hepatol; 2021; 11(2):181-187. PubMed ID: 33746442
[TBL] [Abstract][Full Text] [Related]
5. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis--a concise review.
Shetty S; Ghosh K
Thromb Res; 2011 Jun; 127(6):505-12. PubMed ID: 20961602
[TBL] [Abstract][Full Text] [Related]
6. Budd-Chiari syndrome/hepatic venous outflow tract obstruction.
Valla DC
Hepatol Int; 2018 Feb; 12(Suppl 1):168-180. PubMed ID: 28685257
[TBL] [Abstract][Full Text] [Related]
7. Budd-Chiari syndrome: a common complication of Behçet's disease.
Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
[TBL] [Abstract][Full Text] [Related]
8. Etiology based prevalence of Budd-Chiari syndrome in eastern India.
De BK; De KK; Sen S; Biswas PK; Das TK; Das S; Hazra B
J Assoc Physicians India; 2000 Aug; 48(8):800-3. PubMed ID: 11273472
[TBL] [Abstract][Full Text] [Related]
9. Budd-Chiari syndrome in the course of Behcet's disease: clinical and laboratory analysis of four cases.
Korkmaz C; Kasifoglu T; Kebapçi M
Joint Bone Spine; 2007 May; 74(3):245-8. PubMed ID: 17369069
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt.
Abdel Hameed MR; Elbeih EAS; Abd El-Aziz HM; Afifi OA; Khalaf LMR; Ali Abu Rahma MZ; Sabry A
J Blood Med; 2020; 11():515-524. PubMed ID: 33408545
[TBL] [Abstract][Full Text] [Related]
11. Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome.
Hoekstra J; Janssen HL
Neth J Med; 2008 Sep; 66(8):334-9. PubMed ID: 18809980
[TBL] [Abstract][Full Text] [Related]
12. Budd-Chiari Syndrome as an Initial Presentation of Systemic Lupus Erythematosus Associated with Antiphospholipid Syndrome: A Case Report with Review of the Literature.
Solela G; Daba M
Open Access Rheumatol; 2023; 15():139-143. PubMed ID: 37605776
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
Karaköse S; Oruç N; Zengin M; Akarca US; Ersöz G
Turk J Gastroenterol; 2015 Jan; 26(1):42-8. PubMed ID: 25698270
[TBL] [Abstract][Full Text] [Related]
14. [Oral contraceptives and blood diseases are the most common causes of Budd-Chiari syndrome].
Almer S; Bodemar G; Rydén BO; Elfström J; Franzén L; Ihse I; Resjö M
Lakartidningen; 1989 Nov; 86(46):4002-8. PubMed ID: 2511387
[TBL] [Abstract][Full Text] [Related]
15. [Study on clinical features and etiology of primary Budd-Chiari Syndrome].
Cheng DL; Xu H; Hua R; Xu XJ; Du HT; Qiu H
Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):850-4. PubMed ID: 24331696
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis.
Deepak A; Punamiya S; Patel N; Parekh S; Mehta S; Shah N
Trop Gastroenterol; 2011; 32(4):279-84. PubMed ID: 22696908
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.
Patel RK; Lea NC; Heneghan MA; Westwood NB; Milojkovic D; Thanigaikumar M; Yallop D; Arya R; Pagliuca A; Gäken J; Wendon J; Heaton ND; Mufti GJ
Gastroenterology; 2006 Jun; 130(7):2031-8. PubMed ID: 16762626
[TBL] [Abstract][Full Text] [Related]
18. Is Hepatovenocaval Syndrome a Different Entity from Budd-Chiari Syndrome in Children?
Waheed N; Cheema HA; Suleman H; Mushtaq I; Fayyaz Z; Anjum N
J Coll Physicians Surg Pak; 2018 May; 28(5):344-347. PubMed ID: 29690960
[TBL] [Abstract][Full Text] [Related]
19. [Budd-Chiari syndrome in children and adolescents: therapeutic radiological intervention].
Wang L; Zu MH; Gu YM; Xu H; Zhang QQ; Wei N; Xu W; Cui YF; Teng F; Hua QJ
Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):590-4. PubMed ID: 24225289
[TBL] [Abstract][Full Text] [Related]
20. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.
Qi X; Han G; Guo X; De Stefano V; Xu K; Lu Z; Xu H; Mancuso A; Zhang W; Han X; Valla DC; Fan D
Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1152-1167. PubMed ID: 27734511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
